Renier Brentjens, a CAR T-cell pioneer, views armored CAR T-cells as a promising avenue for treating solid tumors and ...

Recent innovations include engineering CAR T-cells to overcome the immunosuppressive tumour microenvironment and enhancing ...

Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.

Chimeric antigen receptor t-cell, or CAR-T therapy, uses a person’s own immune cells to attack cancer. Dean Berhaupt is the ...

Decoy increases effectiveness of treatment in B-cell acute lymphoblastic leukaemia B-cell Acute Lymphoblastic Leukaemia ...

Immune cells are generated to keep our bodies healthy. To combat disease, our bodies initiate two separate waves of immunity.

Physician-scientists at Memorial Sloan Kettering Cancer Center (MSK) recently published two papers that advance the science ...

Dean Berhaupt has become the first patient to receive CAR T-cell therapy in Albany, marking a significant milestone for cancer treatment in the C ...

Treatment of B-cell acute lymphoblastic leukemia has improved thanks to CAR T therapies, but relapse is still very common. An ...

Several studies have been conducted, but questions remain about where such therapies will fit into multiple myeloma treatment ...

In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...

A multi-institutional team led by The University of Osaka developed a chimeric antigen receptor (CAR) T cell-based strategy ...